Immune-related myocarditis characterized by malignant arrhythmia caused by conduction system involvement: case report and literature review
Immune checkpoint inhibitor (ICI)-related myocarditis has a low incidence but an extremely high mortality rate, and malignant arrhythmia caused by ICI therapy is even rarer. We report our experience of two patients with myocarditis with conduction system involvement after ICI therapy. Both patients...
Saved in:
| Main Authors: | Luying Zhan, Zhiquan Qin, Liu Yang, Yun Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1589990/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incidence and survival outcomes of myocarditis and pericardial diseases associated with immune checkpoint inhibitor therapy
by: Aya F. Ozaki, et al.
Published: (2025-03-01) -
Immune checkpoint inhibitor-induced myocarditis and multiple adverse events with pre-existing rheumatoid arthritis: a case report and literature review
by: Shion Kachi, et al.
Published: (2025-08-01) -
Immune checkpoint inhibitor induced myocarditis, myasthenia gravis, and myositis: A single‐center case series
by: Joshua Longinow, et al.
Published: (2023-02-01) -
Late-Onset Myocarditis Following Immune Checkpoint Inhibitors Therapy: A Case Series with Literature Review
by: Harun Muğlu, et al.
Published: (2025-02-01) -
Management of immune-related myocarditis, myositis and myasthenia gravis (MMM) overlap syndrome: a single institution case series and literature review
by: Alberto Sánchez-Camacho, et al.
Published: (2025-05-01)